D. E. Shaw & Co »

Pmv Pharmaceuticals shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $770k 249k 3.10
2023-09-30 $177k 29k 6.14
2023-06-30 $384k 61k 6.26
2023-03-31 $262k 55k 4.77
2022-12-31 $139k 16k 8.70
2020-12-31 $1.8M 29k 61.53

More positions owned by D. E. Shaw & Co

Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
Booking Holdings (BKNG)
Netflix Put Option (NFLX)
Advanced Micro Devices Put Option (AMD)
Chipotle Mexican Grill (CMG)
Tesla Motors (TSLA)
Uber Technologies Put Option (UBER)
Exxon Mobil Corporation Put Option (XOM)
Citigroup Com New (C)
Alphabet Cap Stk Cl A (GOOGL)
Royal Caribbean Cruises Put Option (RCL)

View all positions for D. E. Shaw & Co

Top funds holding Pmv Pharmaceuticals

OrbiMed Advisors
Jpmorgan Chase & Co
Arrowpoint Asset Management
Euclidean Capital
Vanguard Group
Partner Fund Management
Bank of America Corporation
BML Capital Management
Citadel Advisors
Goldman Sachs Group
Point72 Asset Management
Federated Investors
Vontobel Holding
EcoR1 Capital
Dimensional Fund Advisors

View all funds holding Pmv Pharmaceuticals